SCHEMBL9496

SCHEMBL9496

O=C1CC(O)CCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5071187 1.00
SCHEMBL9275526 1.00
Methane SCHEMBL27607362 0.98
SCHEMBL15705535 0.86
SCHEMBL15705536 0.78
SCHEMBL9717397 0.74 CYP1A2 (0.33)
SCHEMBL3277293 0.74
SCHEMBL574767 0.74
SCHEMBL52211 0.74
SCHEMBL21761546 0.72 ATM (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116574473-A Photovoltaic back adhesive and preparation method thereof 广州富思德化工科技有限公司 2023-08-11 CN claimed
CN-112812724-B Polyester adhesive and preparation method thereof 苏州赛伍应用技术股份有限公司 2022-11-18 CN claimed
CN-112812724-A Polyester adhesive and preparation method thereof 苏州赛伍应用技术股份有限公司 2021-05-18 CN claimed
EP-3478848-A2 METHODS AND MICROORGANISMS FOR PRODUCING FLAVORS AND FRAGRANCE CHEMICALS Ardra Bio Inc. (US) 2019-05-08 EP claimed
WO-2018005806-A2 METHODS AND MICROORGANISMS FOR PRODUCING FLAVORS AND FRAGRANCE CHEMICALS ARDRA BIO INC. (US) 2018-01-04 WO claimed
JP-4786551-B2 2011-10-05 JP claimed
US-7507866-B2 Decarboxylation/hydroxylation without the release of carbon monoxide by using a mixed-oxide, supported, hydrogenation catalyst based on rhenium oxide with an absense of ruthenium and, in some cases, platinum and palladium; autoclaving malic acid to obtain hydroxybutyrolactone and 1,2,4-butanetriol BASF AG (DE) 2009-03-24 US claimed
EP-1716091-B1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOLS OR CARBOXYLIC ACIDS BASF SE (DE) 2009-02-18 EP claimed
US-7439046-B2 Making 4-hydroxy-tetrahydropyran-2-one by converting 2,4-dideoxyhexose or 2,4,6-trideoxyhexose into 4-hydroxy-tetrahydropyran-2-one; 2,4-dideoxyhexose or a 2,4,6-trideoxyhexose prepared from carbonyl compound and acetaldehyde in aldolase and water presence; acetalization, decyclization, cyclization DSM IP ASSETS B.V. (NL) 2008-10-21 US claimed
US-20070135648-A1 Decarboxylation/hydroxylation without the release of carbon monoxide by using a mixed-oxide, supported, hydrogenation catalyst based on rhenium oxide with an absense of ruthenium and, in some cases, platinum and palladium; autoclaving malic acid to obtain hydroxybutyrolactone and 1,2,4-butanetriol BASF AKTIENGESELLSCHAFT (DE) 2007-06-14 US claimed
EP-0418648-B1 4-Hydroxytetrahydropyran-2-ones as well as the corresponding dehydroxy carbon acid derivatives, salts and esters, process for their preparation, pharmaceutical preparations as well as precursors HOECHST AG (DE) 1995-01-11 EP claimed
US-5294724-A Anticholesterol agents HOECHST AKTIENGESELLSCHAFT (DE) 1994-03-15 US claimed
EP-0578016-A2 Enzymatic process for the resolution of a racemic mixture of delta-valerolactones Chemie Linz GmbH (AT) 1994-01-12 EP claimed
US-5266707-A Anticholesterol FUJIREBIO INC. (JP) 1993-11-30 US claimed
US-5149834-A Anticholesterol agent and enzyme inhibitors, for curing arteriosclerosis FUJIREBIO INC. (JP) 1992-09-22 US claimed
EP-0445827-A2 4-Hydroxytetrahydropyran-2-one derivatives useful as cholesterol and lipid reducing agents FUJIREBIO INC. (JP) 1991-09-11 EP claimed
EP-0418648-A1 4-Hydroxytetrahydropyran-2-ones as well as the corresponding dehydroxy carbon acid derivatives, salts and esters, process for their preparation, pharmaceutical preparations as well as precursors HOECHST AKTIENGESELLSCHAFT (DE) 1991-03-27 EP claimed
EP-0306264-A2 Novel HMG-COA reductase inhibitors MERCK & CO. INC. (US) 1989-03-08 EP claimed
EP-0010299-B1 PHARMACEUTICAL COMPOSITION USEFUL FOR THE TREATMENT OF HYPERCHOLESTEREMIA MERCK & CO. INC. (US) 1984-02-15 EP claimed
EP-0010299-A1 Pharmaceutical composition useful for the treatment of hypercholesteremia MERCK & CO. INC. (US) 1980-04-30 EP claimed